May 24, 2010 (New Orleans, Louisiana) – In persons dependent on prescription opioids, tapering with buprenorphine during a 9-month period, whether initially or after a period of substantial improvement, led to nearly universal relapse in the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study, presented here at the American Psychiatric Association 2010 Annual Meeting. Click here for the article. Note: In order to access this article you will need to sign up for a FREE MedScape account, if you do not have one already.
From Medscape Medical News: For Prescription Opioid Dependence, Relapses Associated With Shorter Treatment Course
Call 1 (888) 460-6556 to speak with a counselor.
